About: A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 28 October 2008

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2008 (fr) наукова стаття, опублікована в жовтні 2008 (uk) im Oktober 2008 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 2008 (ast) scientific article published on 28 October 2008 (en)
publication date	wds:Q82639730-28D42D7B-3CB6-40D1-B192-35F85FCBA7BA
publication date	2008-10-28 00:00:00Z (xsd:dateTime)
exact match	wds:Q82639730-CB6C0DB1-D15C-4ACE-8317-D3F0D6971FB8
exact match	https://scigraph.springernature.com/pub.10.1007/s12032-008-9111-x
cites work	wds:Q82639730-0353D693-8060-4169-BCE9-50E75B1D63DD wds:Q82639730-056E8EA2-6945-4875-B27A-BD0B41B67948 wds:Q82639730-0CF000C3-1B1C-404C-8240-54A72BB29609 wds:Q82639730-1EF64C06-BE93-4A65-BDDA-A3FAF8AB8DB6 wds:Q82639730-1F72BF3A-9561-4EFE-AC1E-72100665226D wds:Q82639730-30FF43B9-99A5-45B8-9F9C-75D7653F00F5 wds:Q82639730-3859BFC9-E7F2-4D79-B1BD-59B77D960AA0 wds:Q82639730-3924D86E-2CB9-4282-A500-FE7902B72C87 wds:Q82639730-3BBBA96D-9DE4-47DC-A049-BD5D823CB25F wds:Q82639730-532442CC-C410-41EA-8065-F5566C0FBCA8 wds:Q82639730-66D1C06C-3764-455C-B20C-2248919E1353 wds:Q82639730-6B2F49D0-729A-4CDF-935F-5CD1278AE919 wds:Q82639730-6FDA3D78-68BD-4CDA-9075-BE4AF56C621D wds:Q82639730-7AC85FA1-1263-4754-BC25-70699BFBD30F wds:Q82639730-873F7E4B-027A-40DF-8E6D-0CA4BC488518 wds:Q82639730-882535F3-6DBD-4C03-A92E-DDF49F3C54A5 wds:Q82639730-89082F27-D44C-449F-ABA0-C022B34E4E28 wds:Q82639730-8A33DD9D-1ED2-43A2-B770-4B858B749AFF wds:Q82639730-971B535B-C8E7-4344-8BE4-3C86B0035CD8 wds:Q82639730-A2BD7113-5DA2-44FC-B452-8B18556520EF wds:Q82639730-A69E7409-9751-400E-89FE-3FEC55C0413A wds:Q82639730-B4D1DEF7-4303-4D49-95E6-AD5B7372AC6D wds:Q82639730-BF781C4A-6833-420E-BFA5-A144C07CA323 wds:Q82639730-CA7CB514-025D-4DC7-A1C3-0BE4D60F2946 wds:Q82639730-DDDAC25A-73D7-4768-8BCB-C0677A5B2A58 wds:Q82639730-E729E0DB-F1DE-4C5F-A7AA-1A76989575A2 wds:Q82639730-EC250935-B852-4C3F-887F-E83926D8CEE4 wds:Q82639730-F760D3D2-A5B0-4DF8-A67F-3B9EEE6F7EE1 wds:Q82639730-F89267C9-8510-43E5-AF55-CB1C56B5FD41 wds:Q82639730-FD800684-8AE6-4B67-A7CE-69B5747D8606 wds:Q82639730-FF00AC11-A7F2-434B-83CB-F6A3424ABC74
cites work	Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule Antibody targeted drugs as cancer therapeutics Regression of cutaneous tumor lesions in patients intratumorally injected with a recombinant single-chain antibody-toxin targeted to ErbB2/HER2 Immunotoxins for targeted cancer therapy Frequent EpCam protein expression in human carcinomas Targeted toxin therapy for the treatment of cancer Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. EpCAM (CD326) finding its role in cancer Immunotoxin therapy of cancer Immunotoxin treatment of cancer The biology of the 17-1A antigen (Ep-CAM) Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins Head and neck cancer A retrospective analysis of the outcome of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck refractory to a platinum-based chemotherapy Delivery of molecular and cellular medicine to solid tumors Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer Cetuximab and radiotherapy for head and neck cancer Protein toxin inhibitors of protein synthesis Characterization of vascular leak syndrome induced by the toxin component of Pseudomonas exotoxin-based immunotoxins and its potential inhibition with nonsteroidal anti-inflammatory drugs Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker Effective tumor targeting: strategies for the delivery of Armed Antibodies Molecular targeted therapy of head and neck cancer: review and clinical development challenges Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy A recombinant immunotoxin derived from a humanized epithelial cell adhesion molecule-specific single-chain antibody fragment has potent and selective antitumor activity. Integrating novel agents into the curative treatment of head and neck cancer Cetuximab in squamous cell head and neck carcinomas. Therapeutic immunotoxins for lymphoid malignancies: the end of the beginning
author name string	wds:Q82639730-40A18535-3E2A-4B2F-BE80-AD86B7A9B501 wds:Q82639730-4F7A7AB8-E83A-4A95-A0ED-4CB2EE6CEA13 wds:Q82639730-A323CFDA-5EF8-4605-94E2-70B511C8AD71 wds:Q82639730-ACF794FD-64F1-4D3E-8AB7-64AF4278AFEB wds:Q82639730-DBDE890E-A765-42D9-B4DB-5C3C53AD4A20 wds:Q82639730-E53C67AA-48CE-4161-9C39-2DA4D508DE9F wds:Q82639730-FFFCF83E-A0E6-4B20-9E20-8F65E9A78067
author name string	M Kowalski N Glover J Entwistle G C MacDonald M Rasamoelisolo Maureen A Spearman W Cuthbert
rdfs:label	A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck (en) A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck (nl)
skos:prefLabel	A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck (en) A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck (nl)
name	A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck (en) A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck (nl)
title	wds:Q82639730-2BB6EDAF-4780-4B04-B803-9EBBA7D1DB1E
title	A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck (en)
page(s)	wds:Q82639730-811AF43C-2BFD-4F66-B17A-126BC0437DD5
page(s)	257-264
instance of	wds:Q82639730-BB67C60A-7077-468C-B87D-D7B7738B9DEE
instance of	scholarly article
main subject	wds:Q82639730-43549484-56E7-49A7-A05B-8A2F3A3A9176

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software